Gabapentin Lawsuit

Gabapentin (Neurontin®) may increase a patient’s risk of developing dementia and cognitive impairment. Affected families may be able to file a gabapentin lawsuit against Pfizer, the drug’s manufacturer, for failing to warn about this risk.

At Sokolove Law, we’ve secured over $1.6 Billion for patients harmed by dangerous drugs and medical devices. Call (800) 995-1212 now for a free case review.

Get a Free Case Review

About the Gabapentin Lawsuits for Dementia in 2026

Gabapentin, which is also sold under the brand name Neurontin, is an anti-seizure medication approved by the U.S. Food & Drug Administration (FDA) to treat epileptic seizures and shingles-related nerve pain.

However, the drug has been widely prescribed for a range of unapproved conditions, and studies have linked the medication to an increased risk of dementia and cognitive impairment.

Neurontin and Gabapentin lawsuits allege that Pfizer:

  • Marketed gabapentin for off-label uses, including chronic back pain, bipolar disorder, and migraines
  • Failed to adequately warn patients about the risk of cognitive issues linked to gabapentin use
  • Knew or should have known about these risks, as multiple studies have linked gabapentin to cognitive decline

Patients ages 18-64 who have received 6+ gabapentin prescriptions for back pain are more than twice as likely to develop dementia or mild cognitive impairment, according to Regional Anesthesia & Pain Medicine.

If you or a loved one was prescribed gabapentin and has since been diagnosed with dementia, you may be able to file a gabapentin lawsuit and pursue compensation for medical expenses, pain and suffering, lost wages, and more.

At Sokolove Law, we have over 45 years of experience standing up to negligent pharmaceutical companies and securing justice for patients. Let our gabapentin lawyers fight for you.

Get the Help You Deserve

We’ve helped thousands of families hold powerful companies accountable. Find out if you may be able to file a gabapentin lawsuit now.

Get a Free Case Review

Gabapentin and Dementia Risks

Frequent gabapentin users are 29% more likely to develop dementia and 85% more likely to develop mild cognitive impairment within 10 years, according to a 2025 Case Western Reserve University study.

“This study reinforces what many of us in spine care have warned for years: Gabapentin doesn’t meaningfully help most patients with back pain, but it can hurt them – cognitively, functionally, and long-term.”
– Dr. Dawood Sayed, American Society of Pain and Neuroscience

Other studies have revealed similarly troubling results. Gabapentin use was found to increase the risk of dementia by 45%, according to Frontiers in Pharmacology. Cognitively normal adults also experienced a measurable cognitive decline just 2 years after starting gabapentin, according to the National Alzheimer's Coordinating Center database.

Despite these findings, Pfizer hasn’t updated the warning label on gabapentin to include the risk of dementia or cognitive impairment — and those affected may be able to take legal action against the drug’s manufacturer.

Who Can File a Lawsuit for Gabapentin Memory Loss?

To file a lawsuit for gabapentin memory loss, your attorney must be able to show that you or a loved one used this medication and experienced cognitive decline or memory loss as a result.

You may be eligible for a gabapentin lawsuit if you or a loved one: 

  • Used gabapentin 6 or more times between 2000 and 2024
  • Was prescribed gabapentin for something other than nerve pain or seizures
  • Received an early-onset dementia diagnosis before age 65

There’s only a limited amount of time to file lawsuits against gabapentin due to laws called statutes of limitations. Once the deadline in your case passes, you may lose your chance to seek justice.

Call (800) 995-1212 now to find out if you may qualify for a gabapentin lawsuit settlement. It costs nothing to speak with us.

How to Join the Gabapentin Lawsuit

At Sokolove Law, we understand the challenges you’re experiencing — and we’re here to make sure you don’t have to face them alone. We'll handle every step of the gabapentin lawsuit process and fight for the justice you deserve.

Our gabapentin lawsuit attorneys can:

  • Determine your eligibility to file a claim during a free case review
  • Gather evidence like your medical reports and expert testimony to build a strong case on your behalf
  • File your Neurontin Pfizer lawsuit​ before any legal deadlines
  • Negotiate a gabapentin settlement with the defendant(s), so you can receive compensation as quickly as possible
  • Present your case in court and pursue compensation from a trial verdict if a settlement is unable to be reached

A dementia diagnosis can change everything for you and the people you love. If gabapentin played a role in what your family is going through, you deserve answers, accountability, and compensation.

Pfizer has made billions of dollars selling gabapentin for conditions it was never approved to treat. Taking legal action can allow you to hold the company accountable and seek the financial support your family needs going forward.

Gabapentin Settlements & Verdicts

Pfizer has a long history of being held accountable for their dangerous medications and marketing practices — and gabapentin is no exception. The company has been ordered to pay nearly $1 Billion in fines and settlements linked to gabapentin.

Gabapentin settlements and verdicts include: 

  • $430 Million for illegally promoting off-label uses of gabapentin
  • $190 Million to resolve a consumer fraud Neurontin class action lawsuit​
  • $325 Million for defrauding insurers by marketing gabapentin for unapproved uses

While there’s never a guarantee of compensation in any case, our gabapentin lawsuit lawyers will fight hard to get you everything you’re entitled to.

Compensation from a gabapentin lawsuit may help cover the cost of memory care and assisted living facilities, in-home care, medical expenses like specialist visits or prescription costs, and more.

Let Our Gabapentin Lawyers Fight for You

At Sokolove Law, our gabapentin lawyers have the resources and experience needed to take on major pharmaceutical companies like Pfizer and pursue justice for those harmed by prescription medications.

Find out how Sokolove Law stands out from the rest:

  • Over 45 years of litigation experience
  • No upfront costs or hourly fees
  • Able to help families in all 50 states
  • $1.6 Billion+ secured for victims of dangerous drugs and medical devices

Don't wait: Legal deadlines may limit your ability to file a gabapentin lawsuit. The sooner you reach out, the sooner we can start fighting for you.

Call (800) 995-1212 now or fill out our contact form to get started with a free case review. Our team is standing by to answer any questions you may have.

Gabapentin & Neurontin Lawsuit FAQs

Is there a lawsuit about gabapentin?

Yes. Lawsuits have been filed against Pfizer, the manufacturer of gabapentin (Neurontin®), by patients and families who allege the drug is linked to dementia and other forms of cognitive impairment. Many of these cases involve individuals who were prescribed gabapentin for off-label uses, like chronic back pain.

Gabapentin lawsuits claim that Pfizer knew or should have known about the serious cognitive risks linked to gabapentin use, but they failed to adequately warn patients about this risk.

Contact Sokolove Law now to see if you may be eligible for compensation from a gabapentin lawsuit.

Who makes gabapentin?

Gabapentin was originally developed by Parke-Davis, a subsidiary of Warner-Lambert. It is currently manufactured and marketed by Pfizer, one of the largest pharmaceutical companies in the world.

In 2000, Pfizer acquired Warner-Lambert and has since been the subject of nearly $1 Billion in settlements and penalties tied to gabapentin.

Does gabapentin cause memory loss​?

Research suggests that long-term gabapentin use may be associated with memory loss and other forms of cognitive decline, including early-onset dementia.

Patients who have taken gabapentin should speak with their doctor right away if they begin experiencing memory loss, forgetfulness, confusion, or other similar symptoms.

Is there a gabapentin class action lawsuit?

Currently, there is no open class action lawsuit for dementia caused by gabapentin. Instead, these lawsuits are being filed individually by families across the country.

This approach allows each case to be evaluated based on an individual’s unique circumstances, like the extent of their cognitive decline, their medical history, and how gabapentin has impacted their quality of life.

What is the gabapentin lawsuit payout per person?

The gabapentin lawsuit payout per person will vary depending on the facts of each case. Potential payouts could range from tens of thousands to over $1 Million in more severe cases.

Compensation will likely depend on factors like the severity of the neurological damage, how it has impacted the patient's life, and whether the case is resolved through a gabapentin settlement or verdict.

How do I find the best lawyers for the gabapentin memory loss lawsuit near me?

The best lawyers for a gabapentin memory loss lawsuit may not work at a local firm. Taking on a major pharmaceutical company like Pfizer often requires the extensive resources of a national product liability law firm.

For over 45 years, Sokolove Law has successfully helped thousands of families secure justice, recovering more than $1.6 Billion for those harmed by dangerous drugs and medical devices.

Call (800) 995-1212 now to see if our lawyers for the gabapentin lawsuit​ may be able to fight for you.

How much do gabapentin lawsuit lawyers cost?

At Sokolove Law, there are no upfront costs or hourly fees to work with our gabapentin lawsuit lawyers.

We operate on a contingency-fee basis, which means you pay nothing unless we secure compensation for your family.

  1. Frontiers in Pharmacology. “The association between Gabapentin or Pregabalin use and the risk of dementia: an analysis of the National Health Insurance Research Database in Taiwan.” Retrieved from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10266423/.
  2. Frontiers in Pharmacology. “The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition.” Retrieved from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9732650/.
  3. MedCentral. “Gabapentin and Cognitive Risks in Adults with Back Pain.” Retrieved from: https://www.medcentral.com/meds/pain/gabapentin-and-cognitive-risks-in-adults-with-back-pain.
  4. National Library of Medicine. “Pfizer pleads guilty, but drug sales continue to soar.” Retrieved from: https://pmc.ncbi.nlm.nih.gov/articles/PMC416587/.
  5. Regional Anesthesia & Pain Medicine. “Risk of dementia following gabapentin prescription in chronic low back pain patients.” Retrieved from: ​​https://rapm.bmj.com/content/early/2025/07/02/rapm-2025-106577.long.
  6. U.S. Department of Justice. “WARNER-LAMBERT TO PAY $430 MILLION TO RESOLVE CRIMINAL & CIVIL HEALTH CARE LIABILITY RELATING TO OFF-LABEL PROMOTION.” Retrieved from: https://www.justice.gov/archive/opa/pr/2004/May/04_civ_322.htm.